GlaxoSmithKline ($GSK), which is making big investments in manufacturing in the U.K., will help its homeland try to figure out how to revive its manufacturing base. The drugmaker will oversee an £11 million ($18.4 million) grant for a consortium of 22 life sciences companies to research better ways to manufacture drugs, Genetic Engineering & Biotechnology News reports. The grant is part of a £245 million ($410 million) "supply chain fund," being targeted at the same question across many industries. The effort hopes to find ways to entice U.K. companies to return offshore operations to the U.K. Story | More